CXCL10 and renal cell carcinoma: Although elevated CXCL10 expression was increased in the CD3 + T cell dominant tumors compared to the NK dominant counterparts in all the RCC and ccRCC cases, no statistical differences were observed (Fig. 3Ci and Supplementary Fig. S5Ci, respectively).